A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute
- 2 February 2001
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 37 (2) , 153-158
- https://doi.org/10.1016/s1040-8428(00)00103-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.Journal of Clinical Oncology, 1998
- ChlVPP therapy for Hodgkin's disease: Experience of 960 patientsAnnals of Oncology, 1995
- Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyAnnals of Oncology, 1994
- A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1992
- Non-Hodgkin's lymphoma in the elderly I. Pathologic features at presentationCancer, 1990
- Hodgkin's Disease in Patients 70 Years of Age or More. A Retrospective EORTC Lymphoma Group StudyCancer Investigation, 1990
- Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study.Journal of Clinical Oncology, 1988
- Non-Hodgkin's lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patientsEuropean Journal of Cancer and Clinical Oncology, 1987